Purchase Order HHSN272201200116P
Award Date 12/13/11
Potential Completion Date 2/11/12
Potential Value $8.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Illumina, Inc. in the amount of $14,112.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH). The contract is a firm fixed-price purchase order with no set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, is providing a range of sequencing systems, consumables, and support services under this award to support genomic research and analysis across...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Illumina, Inc. The $5,006.36 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services and support to support genomic sequencing and analysis, with no set-aside designation. Illumina is a manufacturer of genetic and genomic analysis instruments and solutions, and...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $70,000.00 contract is for the provision of various Illumina sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. The contract has no set-aside designation. Illumina has previously...
- This firm fixed-price purchase order contract was awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) on September 16, 2015 for $19,603.58. The contract, which does not have a set-aside designation, is for the provision of Illumina's sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously received prime federal contracts and sub-awards from agencies such as...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The award, valued at $40,892.00, is for the provision of Illumina's products and services to support genomic sequencing and analysis. Illumina has previously been awarded prime federal contracts and subcontracts by various agencies like the NIH, CDC, USDA, and VA to provide...
- This firm-fixed price delivery order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $120,084.75 contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has previously been awarded prime federal contracts and subcontracts to support genomic sequencing and analysis across government agencies like the NIH, CDC, USDA, and VA. This...
- This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $4,266.00, was awarded by the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) for the purchase of various Illumina sequencing systems, reagents, and related services. The contract is a firm fixed-price purchase order with no set-aside designation. Illumina has received...
- This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of Illumina biomedical sequencing instruments and related materials. The $7,998.65 contract is for the purchase of Illumina's sequencing systems, reagents, and consumables to support genomic research and diagnostics. Illumina is a leading manufacturer of genetic analysis...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $5,636.16 contract is for the delivery of Illumina's sequencing systems, reagents, and services to support genomic research and analysis. Illumina, a manufacturer of genetic analysis instruments and consumables, has previously been awarded prime contracts and sub-awards across various federal agencies...
- This is a $32,754.46 firm fixed price delivery order contract awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract provides Illumina's sequencing systems, reagents, and associated services to support genomic research and diagnostics. No set-aside was used. Illumina has previously received other prime federal contract and subcontract awards from agencies like the NIH,...